20mg Total Blend (10mg Tesamorelin / 10mg Ipamorelin) – Lyophilized *MUST BE RECONSTITUTED FOR RESEARCH APPLICATIONS*
Tesamorelin / Ipamorelin Blend is an elite, high-purity multi-peptide formulation pairing a stabilized GHRH analogue (10mg) with a selective ghrelin receptor agonist (10mg) to study maximum growth hormone amplification and metabolic optimization synergy. By concurrently stimulating pituitary somatotrophs and suppressing somatostatin without elevating cortisol or prolactin baselines, this high-dose 1:1 blend serves as an elite investigative tool for tracking visceral adipose tissue (VAT) reduction, accelerated lipid oxidation, lean skeletal muscle retention, and deep slow-wave sleep architecture in laboratory models.
Supplied as a stable, premium-grade lyophilized powder blend in a single high-capacity 20mg vial. Restricted strictly to laboratory and in vitro evaluation.
Eterna Peptides presents premium-grade Tesamorelin and Ipamorelin blend, an elite dual-action growth hormone secretagogue (GHS) research formulation. Combining two distinct, high-purity synthetic peptide chains—Tesamorelin (10mg) and Ipamorelin (10mg)—in a single precisely calibrated 20mg vial, this high-capacity synergistic matrix serves as a premier investigative tool for tracking amplified growth hormone (GH) pulsatility, visceral adiposity reduction, and accelerated lean tissue preservation over extended experimental timelines.
### Advanced 20mg Synergistic Peptide Profile
Each carefully calibrated vial delivers an exact 1:1 mass distribution of targeted secretagogue compounds:
* **Tesamorelin (10mg):** A synthetic 44-amino-acid peptide analogue of endogenous Growth Hormone-Releasing Hormone (GHRH). It features a stabilized hexenoyl group addition that resists enzymatic degradation, allowing intensive evaluation of lipolysis pathways, visceral adipose tissue (VAT) mobilization, and hepatic insulin-like growth factor-1 (IGF-1) transcription.
* **Ipamorelin (10mg):** A highly selective synthetic pentapeptide (Aib-His-D-2-Nal-D-Phe-Lys-NH2) ghrelin receptor agonist. It acts as an elite somatotroph stimulant, driving growth hormone secretion without altering baseline physiological cortisol, prolactin, or aldosterone profiles.
### Mechanism of Action
The Tesamorelin / Ipamorelin matrix targets complementary neuroendocrine receptors to achieve a highly efficient, pulsatile surge in growth hormone:
* **Dual-Pathway Somatotroph Synergy:** Tesamorelin binds directly to GHRH receptors on pituitary somatotroph cells to kickstart growth hormone synthesis. Concurrently, Ipamorelin selectively activates the Growth Hormone Secretagogue Receptor (GHS-R), mimicking ghrelin to suppress somatostatin (growth hormone-inhibiting hormone). This dual action maximizes the amplitude of natural growth hormone pulses.
* **Visceral Adiposity & Lipid Mobilization:** Elevated GH signals downstream lipolysis, driving the reduction of visceral adipose tissue (deep belly fat) and tracking improvements in overall lipid and triglyceride profiles under metabolic stress modeling.
* **Skeletal Muscle Preservation & Growth Factors:** The continuous somatotropic wave prompts the liver to increase circulating levels of Insulin-like Growth Factor-1 ($IGF\text{-}1$), which is monitored for its role in cellular protein synthesis, lean mass preservation, and musculoskeletal recovery kinetics.
* **Deep Sleep & Cognitive Longevity Restoration:** Growth hormone secretagogue signaling is closely monitored in neurobiology for its interaction with slow-wave sleep architecture, tracking deep delta-wave sleep optimization and age-related cognitive performance.
### Research Applications
In preclinical and in vitro laboratory models, Tesamorelin / Ipamorelin blend vials are actively utilized to investigate:
* High-velocity visceral fat reduction, lipolysis kinetics, and metabolic rate adaptation.
* Musculoskeletal tissue remodeling, lean myofibrillar retention, and cellular protein synthesis.
* Selectivity curves of the pituitary GHS-R receptor network and GHRH pathway saturation baselines.
* Delta-wave sleep optimization, cognitive resilience metrics, and somatotropic axis longevity modeling.
Our blend vials undergo strict laboratory stabilization, high-grade purification, and uniform vacuum-drying guidelines to ensure an exact 10mg:10mg ratio, absolute structural purity, and dependable experimental reproducibility.
—
*Disclaimer: This product is sold strictly for laboratory research and development use only. It is not intended for human consumption, diagnostic, or therapeutic purposes.*
